Literature DB >> 2468944

Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig.

C D de Langen1, P A de Graeff, W H van Gilst, K J Bel, J H Kingma, H Wesseling.   

Abstract

The effects of angiotensin II (AII) and captopril (C) on the inducibility of ventricular tachyarrhythmias were investigated 14 days after infarction in pigs. In 27 pigs, ischemia was induced by 60-min occlusion of the left coronary artery. Four pigs died of ventricular fibrillation during ischemia, and six others died within 24 h due to pump failure. Of the 17 survivors, eight pigs developed a sustained (greater than 30 s) monomorphic ventricular tachycardia (sVT) after programmed electrical stimulation. In nine noninducible pigs, an AII infusion (0.6 microgram/kg/min) caused inducible sVT in three animals and nonsustained VT in two animals (greater than 10 reentrant beats). In two of the remaining four animals, spontaneous premature ventricular beats appeared during the infusion. In a group of five healthy pigs, the electrophysiological effects of AII were evaluated. Infusion of AII caused a rapid and sustained increase in arterial blood pressure to 161 +/- 6.4% (p less than 0.001). The sinus cycle length decreased to 74 +/- 5.2% (p less than 0.02). The effective refractory period of the right ventricle decreased significantly to 82 +/- 5.5% (p less than 0.05). These results show that modulation of the renin-angiotensin system after myocardial infarction influences the inducibility of malignant ventricular tachyarrhythmias, as shown by the increased inducibility of sustained ventricular tachycardia. This may be related to a decreased ventricular refractoriness. Therefore, it is suggested that C can reduce malignant ventricular tachycardia late after myocardial infarction by preventing the deleterious arrhythmogenic effects of AII.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468944     DOI: 10.1097/00005344-198902000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.

Authors:  R A Tio; C D de Langen; P A de Graeff; W H van Gilst; K J Bel; K G Wolters; P H Mook; J van Wijngaarden; H Wesseling
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.

Authors:  F X Kleber; L Niemöller; W Doering
Journal:  Br Heart J       Date:  1992-04

3.  Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia.

Authors:  Y Bashir; J F Sneddon; S O'Nunain; V E Paul; S Gibson; D E Ward; A J Camm
Journal:  Br Heart J       Date:  1992-05

4.  Beneficial effects of bradykinin on porcine ischemic myocardium.

Authors:  R A Tio; T J Tobé; K J Bel; C D de Langen; W H van Gilst; H Wesseling
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

5.  Effects of ramipril on ventricular arrhythmia after myocardial infarction in rabbits.

Authors:  Ya Zhong; Ping Cao; Chuan-Feng Tong; Xia Li
Journal:  World J Emerg Med       Date:  2014

Review 6.  Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias.

Authors:  Adriana Adameova; Anureet K Shah; Naranjan S Dhalla
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.